Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma

Authors

Y Wang, Shengjing Hospital of China Medical University
R Rosell, Dexeus University Hospital
F R Hirsch, Mount Sinai School of Medicine
S Lu, Shanghai Jiao Tong University
R Govindan, Washington University School of Medicine in St. Louis
K Park, Sungkyunkwan University
S Peters, Centre Hospitalier Universitaire Vaudois
J J Zhang, University of Texas MD Anderson Cancer Center

Journal

Annals of Oncology

Publication Date

3-1-2026

Volume

37

Issue

3

First Page

289

Last Page

313

Document Type

Open Access Publication

DOI

10.1016/j.annonc.2025.11.008

Rights and Permissions

Wang Y, Rosell R, Hirsch FR, Lu S, Govindan R, Park K, Peters S, Zhang JJ. Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma. Ann Oncol. 2026 Mar;37(3):289-313. doi: 10.1016/j.annonc.2025.11.008. © 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Wang, Y; Rosell, R; Hirsch, F R; Lu, S; Govindan, R; Park, K; Peters, S; and Zhang, J J, "Emerging options and future strategies in immunotherapy for advanced lung squamous-cell carcinoma." Annals of Oncology. 37, 3. 289 - 313. (2026).
https://digitalcommons.wustl.edu/oa_4/6436

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.